SAM Holdings（9G2）年報查詢
SINGAPORE INST OF ADV MED LTD.・新加坡交易所凱利板上市，SSIC 原生分類為Health and Social Services（新加坡標準行業分類，無官方中文版）。 本頁收錄該公司歷年年報與相關報告，PDF 由新加坡交易所（SGX）直接提供。
SAM Holdings 是做什麼的
Incorporated in 2011, Singapore Institute of Advanced Medicine Holdings Ltd. (the "Company" and together with its subsidiaries, the "Group") is a healthcare service provider using advanced technology for early and accurate diagnosis and offering appropriate treatments to achieve better outcomes and quality of life for its patients. The Group’s services cater to a wide spectrum of diseases and health conditions including, but not limited to, cancer, neurodegenerative and cardiovascular disease detection, and treatment. The Group is primarily engaged in the following key business segments: (i) Medical Diagnostics and Treatments; and (ii) Radiation Therapy and Medical Oncology Services. The Company’s goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer. The Group aims to do this by bringing together a dedicated team of professionals and experts from the industry who will work with the Group to seek solutions for the diagnosis and treatment of cancer patients and improve their quality of life.
SAM Holdings 歷年年報與報告
關於 SAM Holdings 年報
SAM Holdings（9G2）年報去哪裡下載？
本頁每個年度都附有 PDF 連結，檔案直接來自新加坡交易所（SGX）的公司公告系統。 目前收錄 2 份年報，年度涵蓋 2024 至 2025。
新加坡上市公司要不要出季報？
2020 年起 SGX 取消了強制季報，改為以風險為基礎——只有特定情況的公司才須刊發季度財務報告。 所以多數新加坡公司一年只有半年度報告與年報兩份定期報告， 本站收錄的季報數量因此偏少，那是制度使然不是資料缺漏。
什麼是永續報告書？
SGX 自 2016 年起要求上市公司刊發永續報告（Sustainability Report），揭露環境、社會與治理（ESG）事項。 它與年報是分開的兩份文件，本站兩種都收。
主板和凱利板有什麼不同？
凱利板（Catalist）門檻較低、面向成長期的中小型企業，由保薦人（sponsor）制度監督； 主板（Mainboard）則有較高的獲利與市值要求。兩者的年報揭露義務相近。